Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis

Jiagui Song, Zhengyang Guo, Decao Yang, Ping Yu, Yinjia Li, Zhuhui Yuan, Xiaojuan Ma, Xianlong Li, Hongyan Guo, Lixiang Xue, Tong Liu

Open source

DOI: 10.1002/ctm2.70885
Published: 2026-11
Container: Clinical and Translational Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70885,
  title = {Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis},
  author = {Jiagui Song and Zhengyang Guo and Decao Yang and Ping Yu and Yinjia Li and Zhuhui Yuan and Xiaojuan Ma and Xianlong Li and Hongyan Guo and Lixiang Xue and Tong Liu},
  year = {2026},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.70885},
  url = {https://doi.org/10.1002/ctm2.70885}
}

RIS

TY  - JOUR
TI  - Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis
AU  - Jiagui Song
AU  - Zhengyang Guo
AU  - Decao Yang
AU  - Ping Yu
AU  - Yinjia Li
AU  - Zhuhui Yuan
AU  - Xiaojuan Ma
AU  - Xianlong Li
AU  - Hongyan Guo
AU  - Lixiang Xue
AU  - Tong Liu
PY  - 2026
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.70885
UR  - https://doi.org/10.1002/ctm2.70885
ER  -

APA

Song, J., Guo, Z., Yang, D., Yu, P., Li, Y., Yuan, Z., Ma, X., Li, X., Guo, H., Xue, L., & Liu, T. (2026). Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70885

Source records

crossref · retrieved 2026-11-03T20:13:37.641Z